Displaying drugs 10926 - 10950 of 11918 in total
5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole
5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. This drug is known to target genome polyprotein.
Experimental
Matched Description: … 5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole is a solid. ... These are aromatic compounds containing an ether group substituted with a benzene ring. …
Thalagen
Thalagen is a branded product developed by San Rocco Therapeutics. It consists of autologous CD34-positive hematopoietic progenitor cells transduced with TNS9.3.55, a lentiviral vector encoding the normal human beta-globin gene. It is being investigated for the treatment of beta-thalassemia.
Investigational
Matched Description: … Thalagen is a branded product developed by San Rocco Therapeutics. ... It consists of autologous CD34-positive hematopoietic progenitor cells transduced with TNS9.3.55, a lentiviral …
DYNE-251
DYNE-251 is a phosphorodiamidate morpholino oligomer (PMO) conjugated to a fragment antibody (Fab) that binds to the transferrin receptor 1 (TfR1). It is being investigated for the treatment of Duchenne muscular dystrophy (DMD) in patients who are amenable to exon 51 skipping.
Investigational
Matched Description: … DYNE-251 is a phosphorodiamidate morpholino oligomer (PMO) conjugated to a fragment antibody (Fab) that …
Rovazolac
Rovazolac is under investigation in clinical trial NCT03175354 (A Study in Subjects With Moderate Atopic Dermatitis).
Investigational
Matched Description: … Rovazolac is under investigation in clinical trial NCT03175354 (A Study in Subjects With Moderate Atopic …
NKTT-120
NKTT-120 is a recombinant humanized IgG1k monoclonal antibody to human invariant T cell receptor (iTCR).
Investigational
Matched Description: … NKTT-120 is a recombinant humanized IgG1k monoclonal antibody to human invariant T cell receptor (iTCR …
NGGT-002
NGGT-002 is a recombinant adeno-associated virus serotype 8 vector encoding human phenylalanine hydroxylase (PAH).
Investigational
Matched Description: … NGGT-002 is a recombinant adeno-associated virus serotype 8 vector encoding human phenylalanine hydroxylase …
LB-P8
LB-P8 is an investigational live biotherapeutic product consisting of a single bacterial strain (Leuconostoc citreum).
Investigational
Matched Description: … LB-P8 is an investigational live biotherapeutic product consisting of a single bacterial strain (_Leuconostoc …
Leflutrozole
Leflutrozole is under investigation in clinical trial NCT02908074 (A 6 Month Safety Extension Study of MBGS205).
Investigational
Matched Description: … Leflutrozole is under investigation in clinical trial NCT02908074 (A 6 Month Safety Extension Study of …
Oxyphenisatin
A laxative that undergoes enterohepatic circulation. It may cause jaundice.
Investigational
Withdrawn
Matched Description: … A laxative that undergoes enterohepatic circulation. It may cause jaundice. …
Itopride
Itopride is a dopamine D2 antagonist with acetylcholinesterase inhibitory actions.
Investigational
Matched Description: … Itopride is a dopamine D2 antagonist with acetylcholinesterase inhibitory actions. …
Clinofibrate
Clinofibrate is a fibrate drug sold and marketed in Japan.
Experimental
Matched Description: … Clinofibrate is a fibrate drug sold and marketed in Japan. …
Cannabigerol
A natural product found in Cannabis sativa and Helichrysum species.
Experimental
Matched Description: … A natural product found in Cannabis sativa and Helichrysum species. …
Cannabichromene
A natural product found in Cannabis sativa and Helichrysum species.
Experimental
Matched Description: … A natural product found in Cannabis sativa and Helichrysum species. …
RO-7293583
RO-7293583 is a TYRP1-Targeting CD3 T-Cell Engager.
Investigational
Matched Description: … RO-7293583 is a TYRP1-Targeting CD3 T-Cell Engager. …
CKD-504
CKD-504 is a novel, selective histone deacetylase 6 inhibitor.
Investigational
Matched Description: … CKD-504 is a novel, selective histone deacetylase 6 inhibitor. …
Mepiprazole
Mepiprazole is a minor tranquilizer with a phenylpiperazine structure. It is a pyrazolyl-alkyl-piperazine derivative. Mepiprazole mediates a weak inhibitory action on the uptake of 5-HT on hypothalamic neurons .
Mepiprazole is marketed in Spain for the treatment of anxiety neuroses.
It acts as a 5-HT2A and α1-adrenergic receptor antagonist, and...
Experimental
Matched Description: … Mepiprazole is a minor tranquilizer with a phenylpiperazine structure. ... It is a pyrazolyl-alkyl-piperazine derivative. ... Mepiprazole mediates a weak inhibitory action on the uptake of 5-HT on hypothalamic neurons [A7816]. …
Nequinate
Nequinate is an antiprotozoan used as a coccidiostat for poultry and rabbits. Nequinate belongs to the family of Hydroquinolones. These are compounds containing an hydrogenated quinoline bearing a ketone group.
Vet approved
Matched Description: … Nequinate is an antiprotozoan used as a coccidiostat for poultry and rabbits. ... These are compounds containing an hydrogenated quinoline bearing a ketone group. …
Guanosine tetraphosphate
Guanosine tetraphosphate is a guanine nucleotide containing four phosphate groups. Two phosphate groups are esterified to the sugar moiety in the 5' position and the other two in the 2' or 3' position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids...
Experimental
Matched Description: … Guanosine tetraphosphate is a guanine nucleotide containing four phosphate groups. ... This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are …
GnRH pharmaccine
The GnRH pharmaccine consists of synthetic peptides (constructed to "look like" GnRH), which are bound chemically to a carrier and suspended in a proprietary "delivery vehicle". The pharmaccine is administered intramuscularly to the patient by injection and induces an immune response or production of antibodies in the patient, which neutralize...
Investigational
Matched Description: … carrier and suspended in a proprietary "delivery vehicle". ... pharmaccine consists of synthetic peptides (constructed to "look like" GnRH), which are bound chemically to a …
5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole
5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. 5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole targets the protein genome polyprotein.
Experimental
Matched Description: … dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole is a ... These are aromatic compounds containing an ether group substituted with a benzene ring. 5-(5-(2,6-dichloro …
CIGB 2020 Vaccine
CIGB 2020 is a vaccine candidate administered nasally and sublingually, working to strengthen immunity in the areas administered. The vaccine was developed and tested by the Center for Genetic Engineering and Biotechnology (CIGB), in Havana Cuba. As of July, 2020, a Randomized control clinical trial (RPCEC00000306) is underway to evaluate...
Investigational
Matched Description: … CIGB 2020 is a vaccine candidate administered nasally and sublingually, working to strengthen immunity ... As of July, 2020, a Randomized control clinical trial (RPCEC00000306) is underway to evaluate prophylaxis …
GRAd-COV2
GRAd-COV2 is a COVID-19 vaccine candidate being developed by ReiThera[L30420, L30423]. This therapy is based on a novel replication-incompetent simian adenoviral vector that encodes the full-length SARS-CoV-2 spike protein (GRAd-COV2)[L30420, L30423]. Preclinical and clinical studies show GRAd-COV2 to induce robust cellular and humoral immune responses .
Investigational
Matched Description: … GRAd-COV2 is a COVID-19 vaccine candidate being developed by ReiThera[L30420, L30423]. ... This therapy is based on a novel replication-incompetent simian adenoviral vector that encodes the full-length …
RUTI® Vaccine
The RUTI® Vaccine contains fragmented, purified and liposomed heat-inactivated Mycobacterium tuberculosis bacilli. The vaccine has demonstrated a reasonable safety profile and potent stimulation of the immune response against tuberculosis. Much like the BCG vaccine, the RUTI® vaccine is also being tested as a prophylactic for SARS-CoV2. Sponsored by Fundació Institut...
Investigational
Matched Description: … The vaccine has demonstrated a reasonable safety profile and potent stimulation of the immune response ... Much like the BCG vaccine, the RUTI® vaccine is also being tested as a prophylactic for SARS-CoV2. ... Institut Germans Trias i Pujol, the RUTI® Vaccine is being tested for prevention of COVID-19 infection in a …
rhIGFBP-3
rhIGFBP-3 (recombinant human insulin-like growth factor binding protein-3) is Insmed’s proprietary anti-cancer compound that has demonstrated significant decreases in cancerous growth in several models of human. It is developed by Insmed and is currently under phase I of the clinical trial.
Investigational
ENMD-1198
Investigational
Displaying drugs 10926 - 10950 of 11918 in total